In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other stocks. Jim Cramer, the host of Mad Money, on Tuesday, took a close look at President Donald ...

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting off on a very different note. According to iSpot.TV’s analysis of ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best cancer stocks to buy. Cancer is the second leading cause of death across the globe ...

An Olympic equestrian athlete had his results from the Paris Olympics thrown out after he inadvertently tested positive for a banned substance after giving his sick dog eye drops. The ...

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a preclinical-stage, oral drug for psoriasis. US-based Nimble was set up in ...

AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically cleared for folate receptor-alpha (FRα) positive, platinum-resistant ...

Ophthalmic nonsteroidal anti-inflammatory agents may increase the risk of bleeding in ocular tissues following ophthalmic procedures (prescribing information, Volaten Ophthalmic, CIBA Vision ...

I’ve said this before: I’m no eye-cream evangelist. I’m a firm believer that your regular moisturizer should work just fine for the skin under your eyes as long as it isn’t too heavy and ...

After hours: 7:54:48 p.m. EST ...